Bryan Oronsky

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 34

Top Venues

Cancer gene therapy

Journal for immunotherapy of cancer

International journal of molecular sciences

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Anthony P Conley, Bryan Oronsky, Scott Caroen, Chris Larson, Tony Reid
Predicting the Abscopal Phenomenon-Letter to the Editor. Molecular cancer therapeutics 23 (2) (2024)
Anthony P Conley, Bryan Oronsky, Scott Caroen, Chris Larson, Tony Reid
Predicting the Abscopal Phenomenon-Letter to the Editor. Molecular cancer therapeutics 23 (2) (2024)
Anthony P Conley, Bryan Oronsky, Scott Caroen, Chris Larson, Tony Reid
Predicting the Abscopal Phenomenon-Letter to the Editor. Molecular cancer therapeutics 23 (2) (2024)
Anthony Conley, Christopher Larson, Bryan Oronsky, Meaghan Stirn, Scott Caroen, Tony R Reid
Hypothesis: AdAPT-001 and pseudoprogression - when seeing is not necessarily believing. Journal for immunotherapy of cancer 12 (6) (2024)
Anthony Conley, Christopher Larson, Bryan Oronsky, Meaghan Stirn, Scott Caroen, Tony R Reid
Hypothesis: AdAPT-001 and pseudoprogression - when seeing is not necessarily believing. Journal for immunotherapy of cancer 12 (6) (2024)
Anthony P Conley, Christina L Roland, Alberto Bessudo, Brian R Gastman, Victoria M Villaflor, Christopher Larson, Tony R Reid, Scott Caroen, Bryan Oronsky, Meaghan Stirn, Jeannie Williams, Erica Burbano, Angelique Coyle, Minal A Barve, Naveed Wagle, Nacer Abrouk, Santosh Kesari
BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors. Cancer gene therapy 31 (4) (2023)
Tao Dong, Jaimin R Shah, Abraham T Phung, Christopher Larson, Ana B Sanchez, Omonigho Aisagbonhi, Sarah L Blair, Bryan Oronsky, William C Trogler, Tony Reid, Andrew C Kummel
A Local and Abscopal Effect Observed with Liposomal Encapsulation of Intratumorally Injected Oncolytic Adenoviral Therapy. Cancers 15 (12) (2023)
Anthony P Conley, Christina L Roland, Alberto Bessudo, Brian R Gastman, Victoria M Villaflor, Christopher Larson, Tony R Reid, Scott Caroen, Bryan Oronsky, Meaghan Stirn, Jeannie Williams, Erica Burbano, Angelique Coyle, Minal A Barve, Naveed Wagle, Nacer Abrouk, Santosh Kesari
BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors. Cancer gene therapy 31 (4) (2023)
Bryan Oronsky, Pedro J Cabrales, Babak Alizadeh, Scott Caroen, Meaghan Stirn, Jeannie Williams, Tony R Reid
TGF-β: the apex predator of immune checkpoints. Future oncology (London, England) (2023)
Anthony P Conley, Christina L Roland, Alberto Bessudo, Brian R Gastman, Victoria M Villaflor, Christopher Larson, Tony R Reid, Scott Caroen, Bryan Oronsky, Meaghan Stirn, Jeannie Williams, Erica Burbano, Angelique Coyle, Minal A Barve, Naveed Wagle, Nacer Abrouk, Santosh Kesari
BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors. Cancer gene therapy (2023)
Christopher Larson, Bryan Oronsky, Tony R Reid
Commentary on oncolytic viruses: past, present, and future. Journal for immunotherapy of cancer 11 (12) (2023)
Christopher Larson, Bryan Oronsky, Tony R Reid
Commentary on oncolytic viruses: past, present, and future. Journal for immunotherapy of cancer 11 (12) (2023)
Anthony P Conley, Christina L Roland, Alberto Bessudo, Brian R Gastman, Victoria M Villaflor, Christopher Larson, Tony R Reid, Scott Caroen, Bryan Oronsky, Meaghan Stirn, Jeannie Williams, Erica Burbano, Angelique Coyle, Minal A Barve, Naveed Wagle, Nacer Abrouk, Santosh Kesari
BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors. Cancer gene therapy 31 (4) (2023)
Bryan Oronsky, Erica Burbano, Meaghan Stirn, Joanne Brechlin, Nacer Abrouk, Scott Caroen, Angelique Coyle, Jeannie Williams, Pedro Cabrales, Tony R Reid
Data Management 101 for Drug Developers: A Peek Behind the Curtain. Clinical and translational science (2023)
Anthony P Conley, Christina L Roland, Alberto Bessudo, Brian R Gastman, Victoria M Villaflor, Christopher Larson, Tony R Reid, Scott Caroen, Bryan Oronsky, Meaghan Stirn, Jeannie Williams, Erica Burbano, Angelique Coyle, Minal A Barve, Naveed Wagle, Nacer Abrouk, Santosh Kesari
BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors. Cancer gene therapy 31 (4) (2023)
Christopher Larson, Bryan Oronsky, Tony R Reid
Commentary on oncolytic viruses: past, present, and future. Journal for immunotherapy of cancer 11 (12) (2023)
Anthony P Conley, Christina L Roland, Alberto Bessudo, Brian R Gastman, Victoria M Villaflor, Christopher Larson, Tony R Reid, Scott Caroen, Bryan Oronsky, Meaghan Stirn, Jeannie Williams, Erica Burbano, Angelique Coyle, Minal A Barve, Naveed Wagle, Nacer Abrouk, Santosh Kesari
BETA prime: a first-in-man phase 1 study of AdAPT-001, an armed oncolytic adenovirus for solid tumors. Cancer gene therapy 31 (4) (2023)
Tao Dong, Jaimin R Shah, Abraham T Phung, Christopher Larson, Ana B Sanchez, Omonigho Aisagbonhi, Sarah L Blair, Bryan Oronsky, William C Trogler, Tony Reid, Andrew C Kummel
A Local and Abscopal Effect Observed with Liposomal Encapsulation of Intratumorally Injected Oncolytic Adenoviral Therapy. Cancers 15 (12) (2023)
Ching-Hsin Huang, Tao Dong, Abraham T Phung, Jaimin R Shah, Christopher Larson, Ana B Sanchez, Sarah L Blair, Bryan Oronsky, William C Trogler, Tony Reid, Andrew C Kummel
Full Remission of CAR-Deficient Tumors by DOTAP-Folate Liposome Encapsulation of Adenovirus. ACS biomaterials science & engineering (2022)
Bryan Oronsky, Brian Gastman, Anthony P Conley, Christopher Reid, Scott Caroen, Tony Reid
Oncolytic Adenoviruses: The Cold War against Cancer Finally Turns Hot. Cancers 14 (19) (2022)
Santosh Kesari, Alberto Bessudo, Brian R Gastman, Anthony P Conley, Victoria M Villaflor, Lisle M Nabell, DeLisa Madere, Emma Chacon, Christina Spencer, Li Li, Christopher Larson, Tony Reid, Scott Caroen, Bryan Oronsky, Meaghan Stirn, Jeannie Williams, Minal A Barve
BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumors. Future oncology (London, England) 18 (29) (2022)
Terese Catherine Hammond, Raymond C Lee, Bryan Oronsky, Tony R Reid, Scott Caroen, Tiffany M Juarez, Jaya Gill, Annie Heng, Santosh Kesari
Clinical Course of Two Patients with COVID-19 Respiratory Failure After Administration of the Anticancer Small Molecule, RRx-001. International medical case reports journal 15 (2022)
Bryan Oronsky, Scott Caroen, Tony Reid
What Exactly Is Inflammation (and What Is It Not?). International journal of molecular sciences 23 (23) (2022)
Bryan Oronsky, Scott Caroen, Tony Reid
What Exactly Is Inflammation (and What Is It Not?). International journal of molecular sciences 23 (23) (2022)
Bryan Oronsky, Scott Caroen, Tony Reid
What Exactly Is Inflammation (and What Is It Not?). International journal of molecular sciences 23 (23) (2022)
Bryan Oronsky, Scott Caroen, Tony Reid
What Exactly Is Inflammation (and What Is It Not?). International journal of molecular sciences 23 (23) (2022)
Terese Catherine Hammond, Raymond C Lee, Bryan Oronsky, Tony R Reid, Scott Caroen, Tiffany M Juarez, Jaya Gill, Annie Heng, Santosh Kesari
Clinical Course of Two Patients with COVID-19 Respiratory Failure After Administration of the Anticancer Small Molecule, RRx-001. International medical case reports journal 15 (2022)
Jaimin R Shah, Tao Dong, Abraham T Phung, Tony Reid, Christopher Larson, Ana B Sanchez, Bryan Oronsky, Sarah L Blair, Omonigho Aisagbonhi, William C Trogler, Andrew C Kummel
Development of Adenovirus Containing Liposomes Produced by Extrusion vs. Homogenization: A Comparison for Scale-Up Purposes. Bioengineering (Basel, Switzerland) 9 (11) (2022)
Bryan Oronsky, XiaoNing Guo, XiaoHui Wang, Pedro J Cabrales, David Sher, Lou Cannizzo, Bob Wardle, Nacer Abrouk, Michelle Lybeck, Scott Caroen, Arnold Oronsky, Tony R Reid
Discovery of RRx-001, a Myc and CD47 Downregulating Small Molecule with Tumor Targeted Cytotoxicity and Healthy Tissue Cytoprotective Properties in Clinical Development. Journal of medicinal chemistry 64 (11) (2021)
Bryan Oronsky, Christopher Larson, Terese C Hammond, Arnold Oronsky, Santosh Kesari, Michelle Lybeck, Tony R Reid
A Review of Persistent Post-COVID Syndrome (PPCS). Clinical reviews in allergy & immunology (2021)
Bryan Oronsky, Tony R Reid, Christopher Larson, Scott Caroen, Mary Quinn, Erica Burbano, Gina Varner, Bennett Thilagar, Bradley Brown, Angelique Coyle, Lindsey Ferry, Nacer Abrouk, Arnold Oronsky, Curtis L Scribner, Corey A Carter
REPLATINUM Phase III randomized study: RRx-001 + platinum doublet versus platinum doublet in third-line small cell lung cancer. Future oncology (London, England) 15 (30) (2019)
Bryan Oronsky, Curtis Scribner, Rahul Aggarwal, Pedro Cabrales
RRx-001 protects normal tissues but not tumors via Nrf2 induction and Bcl-2 inhibition. Journal of cancer research and clinical oncology 145 (8) (2019)
Bryan Oronsky, Eilleen S Y Ao-Ieong, Ozlem Yalcin, Corey A Carter, Pedro J Cabrales
Cardioprotective Effect of Phase 3 Clinical Anticancer Agent, RRx-001, in Doxorubicin-Induced Acute Cardiotoxicity in Mice. Molecular pharmaceutics 16 (7) (2019)
Michelle Ojemuyiwa, Karen Zeman, Alexander Spira, Bryan Oronsky, Carolyn Ray, Jane B Trepel, Min-Jung Lee, Ifeyinwa Onyiuke, Christina Brzezniak
Complete metabolic response of metastatic castration-resistant neuroendocrine carcinoma of the prostate after treatment with RRx-001 and reintroduced platinum doublets. Clinical case reports 6 (12) (2018)

Bryan Oronsky.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bryan Oronsky